Back to Resources
- Overall, the European HIV market focused on healthcare professionals with digital direct mail, targeting mostly Italian physicians. The main topics included efficacy, prevention, copay elimination, and non-inferiority of their brands.
- ViiV Healthcare and Johnson & Johnson featured Vocabria + Rekambys’s demonstrated efficacy, adherence, persistence, and non-inferiority across multiple studies, as well as long-injectable dosing every two months. The combination also eliminated the €20 copay in Germany and announced its GeSIDA endorsement. The familiar “It Starts With You” campaign was observed.
- ViiV Healthcare featured Apretude as a preventive strategy for certain groups, while Dovato highlighted its benefits and non-inferiority, even in patients with high viremia. The “Future” campaign for Dovato was displayed.
- Additional insights available within this CDP: SnapShot report.
Questions about this SnapShot or other markets?
U.S. MARKETS
Christine Alongi
alongi@dtwresearch.com
GLOBAL MARKETS
Robin Cefalo
cefalo@dtwresearch.com
SOCIAL MEDIA MARKETS
Andrew Carney
carney@dtwresearch.com